BillionToOne, Inc.
BLLN Nasdaq· Services-Medical Laboratories
Last close · Oct 27, 2026
$114.07
KIRA · Stoqly’s AI analyst, in plain words
- BillionToOne, Inc. had $305M of revenue in fiscal 2025, up 100.0% on the year before.
- Its operating margin was 5.3%, up 36.2 pts: of every 100 in sales, about 5 is left after running the business.
- BillionToOne, Inc. made $7.5M of net profit in fiscal 2025.
- Free cash flow was $15.7M in fiscal 2025, 5.2% of revenue.
- BillionToOne, Inc. returned $0.0M to shareholders in fiscal 2025, 0% of free cash flow. The diluted share count rose 110.6%.
- BillionToOne, Inc. has $438M more cash than debt.
Market cap
$6.2B
P/E
109.7x
Revenue
$305M
Net income
$7.5M
Free cash flow
$15.7M
Operating margin
5.3%
BillionToOne, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+100.0%
Yes. Sales grew 100.0% last year.
Does it make a profit?
2.4%
A little. It keeps 2.4% of every sale as profit.
Does profit turn into cash?
5.2%
Partly. 5.2% of sales ends up as free cash.
Is debt under control?
Net cash
Yes. It has more cash than debt.
How healthy are the accounts?
7 / 9
Solid. It passes 7 of 9 health tests.
How is the share priced?
109.7x
One share costs 109.7 times its yearly profit per share.
What BillionToOne, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 11, 2026
- Legal name
- BillionToOne, Inc.
- CIK
- 0002070849
BillionToOne, Inc. · BLLN
Results and finances
The last 3 fiscal years. Amounts in USD.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Sales and profit | |||
| Revenue | $71.7M | $153M | $305M |
| Revenue growth | — | 112.7% | 100.0% |
| Gross margin | 24.1% | 53.0% | 68.3% |
| Operating margin | −96.9% | −30.9% | 5.3% |
| Net income | −$82.7M | −$41.6M | $7.5M |
| Net margin | −115.3% | −27.2% | 2.4% |
| Diluted EPS | −$8.45 | −$4.12 | $0.14 |
| Cash | |||
| Cash from operations | −$53.7M | −$41.4M | $24.6M |
| Capital expenditure | $6.2M | $5.4M | $8.9M |
| Free cash flow | −$59.8M | −$46.8M | $15.7M |
| FCF margin | −83.4% | −30.7% | 5.2% |
| Share buybacks | $0.0M | $0.5M | $0.0M |
| Share count change | — | 3.0% | 110.6% |
| Debt and strength | |||
| Cash and short-term investments | $97.3M | $191M | $496M |
| Debt incl. finance leases | — | $51.5M | $58.1M |
| Shareholders' equity | −$219M | −$252M | $480M |
| Net debt / EBITDA | — | — | −19.1x |
| Current ratio | — | 8.0x | 11.7x |
| Interest coverage | −21.2x | −19.8x | 168.7x |
| Returns and quality | |||
| Return on capital | — | — | 37.2% |
| Return on equity | — | — | 6.5% |
| Return on tangible equity | — | — | 0.6% |
| Piotroski F-score | — | — | 7 |
| Altman Z'' | — | −1.7 | 7.4 |
Insiders bought, 12 months
$3.2M
6 insiders
Insiders sold, 12 months
$48.1M
6 insiders
Of sales under plans
100%
$48.1M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
BillionToOne, Inc. · BLLN
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $114.07 a share, the company is worth $6.2B: 109.7 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0002070849). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.